| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 73486 |
Fmoc-NH-PEG6-CH2COOH，cas:437655-96-4 |
57 |
zyl |
2024-12-18 |
| 73487 |
cas:557756-85-1，Fmoc-NH-PEG4-CH2CH2COOH，5,8,11,14-四氧杂-2-氮杂十七烷二酸1-(9H-芴-9-基甲基)酯 |
80 |
kx |
2024-12-18 |
| 73488 |
DOTA-3-酪氨酰基-奥曲肽 DOTA-TATE |
72 |
h |
2024-12-18 |
| 73489 |
DBCO-DOTA-Eu 叠氮功能化修饰OTA-Eu |
157 |
h |
2024-12-18 |
| 73490 |
HO-PEG10-CH2COOtBu |
73 |
zyl |
2024-12-18 |
| 73491 |
cas:1026987-94-9，DUPA(OtBu)-OH |
66 |
kx |
2024-12-18 |
| 73492 |
NOTA/DFO-MAL-Cys-MZHER2 亲和体Cys-MZHER2偶联螯合剂NOTA/DFO-MAL |
79 |
h |
2024-12-18 |
| 73493 |
N-DBCO-N-bis(PEG2-amide-PEG4-Val-Cit-PAB-MMAE) |
78 |
WYQ |
2024-12-18 |
| 73494 |
Propargyl-PEG2-CH2CO2-NHS ester，cas:2244145-13-7 |
75 |
zyl |
2024-12-18 |
| 73495 |
NHS ester-PEG4-Val-Cit-PAB-MMAE，（二苯并环辛炔N-羟基琥珀酰亚胺酯） |
162 |
WYQ |
2024-12-18 |
| 73496 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸-1-柰丙氨酸-奥曲肽 DOTA-NOC |
71 |
h |
2024-12-18 |
| 73497 |
CAS号为1350456-56-2的Fmoc-Val-Cit-PAB-MMAE |
64 |
WYQ |
2024-12-18 |
| 73498 |
Azido-PEG3-CH2CO2Me，cas:1253389-31-9 |
64 |
zyl |
2024-12-18 |
| 73499 |
cas:60444-78-2，Ald-Ph-NHS ester，4-甲酰苯甲酸N-琥珀酰亚胺酯 |
120 |
kx |
2024-12-18 |
| 73500 |
荧光染料sulfo-Cy5.5-NHS酯 |
103 |
h |
2024-12-18 |
| 73501 |
DOTA-NVVRQ DOTA-TMTP1 双功能螯合剂DOTA偶联多肽TMTP1(NVVRQ) |
84 |
h |
2024-12-18 |
| 73502 |
CAS号为2353409-69-3的Mal-PEG8-Val-Cit-PAB-MMAE |
94 |
WYQ |
2024-12-18 |
| 73503 |
聚DOTA新型树枝状分子(PDOTA) |
91 |
h |
2024-12-18 |
| 73504 |
Anti-EGFR (cetuximab)-EDC/NHS-methotrexate |
142 |
kx |
2024-12-18 |
| 73505 |
CAS号为646502-53-6的MC-Val-Cit-PAB-MMAE |
128 |
WYQ |
2024-12-18 |
| 73506 |
介孔硅纳米粒子(MSNs) |
172 |
h |
2024-12-18 |
| 73507 |
DO3A-Ether-Rhein 10-{[6-(1,8-二羟基蒽醌-3-甲酰氨基)乙氧基乙基]氨基}羰酰甲基-1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸 |
88 |
h |
2024-12-18 |
| 73508 |
MC-Val-Cit-PAB-MMAF（或简写为Vc-MMAF） |
91 |
WYQ |
2024-12-18 |
| 73509 |
Anti-CD33 (h2H12ec)-Mc-VC-SGD-1882， ADC试剂 |
103 |
kx |
2024-12-18 |
| 73510 |
FITC-cNGR 绿色荧光素FITC标记cNGR环状 |
91 |
h |
2024-12-18 |
| 73511 |
Azide-PEG3-Val-Cit-PAB-MMAF，叠氮-三聚乙二醇-Val-Cit-PAB-MMAF |
80 |
WYQ |
2024-12-18 |
| 73512 |
cas:2454675-51-3，t-butyl-C18-D-Glu-OtBu，ADC定制 |
91 |
wyh |
2024-12-18 |
| 73513 |
包裹瑞喹莫德的PS脂质体（PS-R848）,包裹R848的PS仿生脂质体 |
176 |
axc |
2024-12-18 |
| 73514 |
MC-Val-Cit-Doxorubicin（CAS号：159857-70-2） |
80 |
WYQ |
2024-12-18 |
| 73515 |
Anti-CD22 (clone G5/44)-AcBut-CalichDMH，ADC定制 |
78 |
kx |
2024-12-18 |
| 73516 |
cas:870487-07-3，Fmoc-Lys(Boc)-PAB-PNP，ADC定制 |
80 |
wyh |
2024-12-18 |
| 73517 |
cas:2055042-67-4，Azido-PEG4-Ala-Ala-Asn(Trt)-PAB，ADC定制 |
103 |
wyh |
2024-12-18 |
| 73518 |
蜚蠊提取物长效脂质体,CE-Lip,靶向脂质体定制服务 |
122 |
axc |
2024-12-18 |
| 73519 |
cas:150114-97-9，Fmoc-Val-Ala-OH ，Fmoc-L-缬氨酰-L-丙氨酸 |
84 |
kx |
2024-12-18 |
| 73520 |
Biotin-PEG11-Gly-Gly-Gly-Amine，生物素-PEG11-甘氨酸三肽-胺，ADC定制 |
64 |
wyh |
2024-12-18 |
| 73521 |
Azido-PEG4-Val-Ala-PAB-PNP，由叠氮基团（-N3）、PEG4、Val、Ala、PAB和PNP组成 |
120 |
WYQ |
2024-12-18 |
| 73522 |
三分枝脂质体配体,3RGD-Chol,提供荧光脂质体定制服务 |
106 |
axc |
2024-12-18 |
| 73523 |
cas:1343476-44-7，Val-Ala-PAB-OH ， ADC试剂 |
77 |
kx |
2024-12-18 |
| 73524 |
cas:28320-73-2，Boc-Gly-Gly-Gly-OH，ADC定制 |
112 |
wyh |
2024-12-18 |
| 73525 |
双分枝脂质体配体,2RGD-Chol,脂质体纳米载体定制服务 |
97 |
axc |
2024-12-18 |
| 73526 |
MC-Val-Cit-PAB-Gly， ADC试剂 |
81 |
kx |
2024-12-18 |
| 73527 |
DBCO-PEG4-Val-Ala-PAB，由DBCO、PEG4、Val、Ala和PAB组成 |
82 |
WYQ |
2024-12-18 |
| 73528 |
DBCO-PEG4-Val-Ala-PAB-PNP |
71 |
WYQ |
2024-12-18 |
| 73529 |
1343407-91-9，Alloc-Val-Ala-PAB-OH，ADC定制 |
109 |
wyh |
2024-12-18 |
| 73530 |
cas:870487-09-5，Boc-Val-Cit-PAB |
86 |
kx |
2024-12-18 |
齐岳微信公众号
官方微信
库存查询